Company Filing History:
1 out of 1,187 
1 out of 2,596 
1 out of 411 
Years Active: 1995
Title: Alvise Bernabei: Innovator in Blood Coagulation Inhibition
Introduction
Alvise Bernabei is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medicine, particularly in the area of blood coagulation. His innovative approach has led to the development of a method that enhances patient safety during extracorporeal circulation procedures.
Latest Patents
Bernabei holds a patent for a method of inhibiting blood coagulation in extracorporeal circulation. This invention provides a method of inhibiting coagulation in a subject by administering a therapeutically effective amount of a monoclonal antibody that inhibits the ability of tissue factor to bind to factor VII/VIIa. The method effectively prevents complex formation between tissue factor and factor VII/VIIa, thereby inhibiting blood coagulation during procedures such as cardiopulmonary bypass and other shunt procedures. The anti-tissue factor monoclonal antibodies produced by hybridoma cell lines TFS-5G9 or TF9-6B4 may be utilized in these methods. Bernabei has 1 patent to his name.
Career Highlights
Throughout his career, Bernabei has worked with prestigious institutions such as The Scripps Research Institute and the University of Pennsylvania. His work has been instrumental in advancing medical technologies that improve patient outcomes during complex surgical procedures.
Collaborations
Bernabei has collaborated with esteemed colleagues, including Thomas S. Edgington and Robert W. Colman. These partnerships have contributed to the development of innovative solutions in the medical field.
Conclusion
Alvise Bernabei's contributions to the field of blood coagulation inhibition demonstrate his commitment to advancing medical science. His innovative methods have the potential to significantly improve patient care during extracorporeal procedures.